TOXICOLOGICAL PROFILE ON AYAPODI ELAGAM - A SIDDHA HERBOMINERAL FORMULATION IN WISTER ALBINO RATS by A, *Kalaivani et al.
ISSN: 2322 - 0902 (P) 
ISSN: 2322 - 0910 (O) 
     IJAPR | December 2018 | Vol 6 | Issue 12  8 
International Journal of Ayurveda  
and Pharma Research 
 
Research Article 
 
TOXICOLOGICAL PROFILE ON AYAPODI ELAGAM - A SIDDHA HERBOMINERAL FORMULATION IN 
WISTER ALBINO RATS 
A.Kalaivani1*, K.Jeevaraj1, P.Shanmugapriya2, R.Madhavan3 
*1PG Scholar, 2Guide and Lecturer, 3HOD i/c, Dept. of. Nanju Maruthuvam, National Institute of Siddha, Chennai, 
Tamil nadu, India. 
ABSTRACT 
Ayapodi Elagam (A.E) was used in Siddha system of medicine for many years to treat Pandu 
(Anemia). This medicine contains Nellikai, Keezhanelli, Karisalai and Ayam. These herbs are 
helps to improve the blood to correct the anemia. This study was carried out to evaluate the 
acute and chronic toxic effect on Ayapodi Elagam and to determine the LD50. The toxicity study 
was done as per the guidelines of world health organization (WHO) guideline. As the herbs and 
Ayam were used for treating anemia by traditional practitioners for years together, the toxicity 
study was also proposed to study in both sexes. In acute study the animals were divided into two 
groups A.E was administered at 5000mg/kg orally and animals were observed for toxic sign at 
0,5,1,4,24 hour and for 14 days. In chronic toxicity study A.E was administered at 450,900 and 
1800 mg/kg body weight/day to 3 groups of animal, respectively. The distilled water was 
administered to control animals. The result showed that the acute toxicity study of A.E. at the 
dose level of 5000mg/kg does not produce any toxic sign and mortality among the experimental 
groups and the LD50 value of the drug was found to be more than 5000mg/kg bodyweight. The 
weight of rats, wellness parameters, mortality, hematological parameters, biochemical 
parameters and histological analysis of all vital organs were observed to know the chronic toxic 
effect of the drug. All the parameters of the study do not show the any significant chances 
between the control and experimental groups.  
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INTRODUCTION
Anaemia is the most prevalent nutritional 
deficiency disorder in the world. It is a condition that 
occurs when the red blood cells do not carry enough 
oxygen to the tissues of the body. According to World 
Health Organization criteria, anemia is defined as 
blood hemoglobin (Hb) concentration <130 g/L (<13 
g/dL) or hematocrit (Hct) <39% in adult males; Hb 
<120 g/L (<12 g/dL) or Hct<37% in adult females. 
Signs and symptoms of anaemia are varied, 
depending on the level of anaemia and the time 
course over which it developed. A physiologic 
approach to anaemia diagnosis is based on the 
understanding that a decrease in circulating RBCs can 
be related to either inadequate production of RBCs or 
increased RBC destruction or loss. Within the 
category of inadequate production, erythropoiesis 
can be either ineffective, due to an erythrocyte 
maturation defect, or hypoproliferative.[1] 
Most of the anemia’s are due to an inadequate 
supply of nutrients like iron, folic acid and vitamin 
B12, proteins, amino acids, vitamins A, C, and other 
vitamins of B-complex group i.e., niacin and 
pantothenic acid are also involved in the 
maintenance of Haemoglobin level. Globally, anaemia 
affects 1.62 billion people, which corresponds to 
24.8% of the population. The highest prevalence is in 
preschool-age children (47.4%), and the lowest 
prevalence is in men (12.7%) Prevalence of anaemia 
in all the groups is higher in India as compared to 
other developing countries. In India, anaemia affects 
an estimated 50% of the population. The problem 
becomes more severe as more women are affected by 
it as compared to men.[2] 
 In Siddha science anemia is called by the 
name Pandu (or) Veluppu noi. In Veluppu noi the 
appetite is lost. The food taken will not be digested 
well, which result in anemia and body weakness. 
Besides these Anal pitham and the Ranjaga pitham 
which gives the natural colour to our skin are 
affected in this disease. The body will be pale and 
loses its weight. It will increase the ‘Azhal’ humour 
the increased Azhal humour also increases the other 
two humours and Vyanan which result in Pandu 
(anemia).[3] 
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Ayapodi Elagam is one among the Elagam 
preparation in Siddha system of medicine. The 
ingredient of the drug was Ayam (Iron), Nellikai 
(Phyllanthus emblica), Keezhanelli (Phyllanthus 
niruri) and Karisalai (Eclipta alba). It is used for 
treating anaemia, jaundice. Iron is the most 
important metal used in Siddha system of medicine 
for treating anemia. The herbal drugs also help to 
reduce the Azhal humour. The medicine Ayapodi 
Elagam is used by many Siddha practitioners to treat 
anemic patients. But safety of the Ayapodi Elagam is 
not known. Hence I want to evaluate the toxicity of 
Ayapodi Elagam in animal model acute and long term 
toxicity study as per WHO guideline. 
MATERIALS AND METHODS 
Collection and Authentication of Raw Drugs 
Ayam was collected from Trichy river bed. 
And other herbal drugs were collected from 
vegetable market, Tambaram, Chennai.  
 The mineral drug Ayam were identified and 
authenticated by Lecturer, Department of 
Gunapadam, National Institute of Siddha, Chennai. 
The herbal drugs Nellikai (Phyllanthus 
emblica), Keezhanelli (Phyllanthus niruri), Karisalai 
(Eclipta alba) were identified and authenticated by 
Assistant Professor, Department of Medicinal Botany, 
National Institute of Siddha, Chennai.  
Ingredients  
       
Nellikai    Karisalai    Keezhanelli 
 
    
Vellam     Honey 
     
Ayam before Purification  Ayam after Purification 
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Preparation of the Test Drug 
Purified Ayapodi (iron powder)-280gm, 
Nellikai chaaru (Phyllanthus emblica juice)-140gm, 
Keezhanellic hamoolachaaru (Phyllanthus niruri 
whole plant extract) - 140gm, Karisalai chaaru 
(Eclipta alba plant extract) -105gm, Purified honey - 
87.5g, Jaggery (Vellam) – 70gm was taken. The 
extract were mixed with the Ayapodi in a mortar and 
grind it for twelve hours, the resultant product was 
put in an iron pot; mix it well in the remaining part of 
the extracts and heat the pot slowly. Stir well with an 
iron, honey and jaggery ‘Vellam’. When cool pour the 
paste into a porcelain vessel and keep it for use.[4] 
Animals and Husbandary 
 Male and female Wistar albino rats weighing 
150-750gm were used for the study. Animals were 
housed in groups (3-5/cage) in polypropylene cages 
in the well ventilated room under an ambient 
temperature of 22°C (±3°) and relative humidity 30–
70% 12-h light/12-h dark cycle. They were provided 
with food and purified water ad libitum. All the 
animals were acclimatized at least for 7 days to the 
laboratory conditions prior to the study. The cages 
were labelled with group, weight of the animal and 
day of drug administration. Separate record was 
maintained for each animal in all the groups 
including control animals. Guidelines of CPCSEA, 
laboratory animal care were strictly followed 
throughout the study. This study was carried out 
with the approval of Institutional Animal Ethic 
Committee (IAEC), National Institute of Siddha. 
(NIS/IAEC-I/2016/10)[5] 
Acute toxicity study 
Acute toxicity study was performed as per the 
WHO guideline. Young adult Wistar albino rats male 
and female weighing 150-750gm were used for the 
study. One week after acclimatization, 20 animals 
were selected and divided into two groups control 
and test group. Control group received distal water; 
the test group was treated with A.E. at the dose level 
of 5000mg/kg b.wt by oral gavage. All the study 
animals were observed for their behavioral sign and 
mortality at 30 mints, 1,2,4 hours upto 24 hours and 
then followed for further 14 days. At the end of the 
14th day, the overnight fasted animals were sacrificed 
by using excessive anesthesia and subjected to gross 
pathological examination. 
Long term toxicity study 
According to WHO guideline the chronic 
toxicity study was carried. The animals in both sexes 
were divided in four groups each group consists of 10 
animals (5 male and 5 female).Control group 
received distal water. A.E was administered at 
450,900 and 1800 mg/kg b.wt/day to 3 groups of 
animal, respectively. All the animals were treated 
once daily for 90 days. The sign of toxicity and 
mortality were monitored for 90 days. Body weight 
were Calculated weekly once. Feed & water intake 
were Calculated daily. The overnight fasted animals 
were sacrificed after 90 days except the high dose 
group four animals. The high dose group two male 
and two female animals were set as satellite group. 
The satellite groups were sacrificed on after 30 days. 
Blood samples were collected from abdominal aorta 
under excessive anaesthesia with and without 
anticoagulant and used for haematological and 
biochemical parameters. 
The haematological parameters were 
analysed by using fully automated haematology 
analyser. Plasma was separated and used for the 
estimation of biochemical parameters. 
Histopathology examination of organs 
The organs included liver, kidney, spleen, 
brain, heart, lung, stomach and bone marrow of the 
animals were preserved and they were subjected to 
histopathological examination.  
The organ pieces (35µm thick) of all the 
animals (control, high dose and satellite group) were 
preserved and fixed in 10% formalin for 24 hrs. 
Samples were dehydrated in an auto technic and then 
cleared in benzene to remove absolute alcohol. 
Embedding was done by passing the cleared samples 
through three cups containing molten paraffin at 
50oC and then in a cubical block of paraffin made by 
the “L” moulds. It was followed by microtome and the 
slides were Prepared then stained with 
Haematoxylin-eosin. 
Bone Marrow Smear 
About 0.2 ml of smear aspirated from the 
femur thigh bone of the experimental animal was 
dropped onto the glass slide and made in to thin 
smear allow the smear to dry. Dried smear was 
stained with leishman stain and washed. Followed by 
this cedar wood oil was placed on to the smear and 
was observed microscopically.[6] 
Statistical analysis 
Findings such as body weight changes, food 
consumption, water intake, hematology and 
biochemical analysis were subjected to One-way 
ANOVA Dennett’s test using a computer software 
program followed by Graph Pad Instat-3.[7] 
RESULTS 
Acute toxicity study 
 Acute toxicity of Ayapodi Elagam does not 
produce any toxicity signs and mortality at the dose 
level of 5000mg/kg b.wt in the animal during 14 days 
of the study. Further the gross necropsy revealed no 
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abnormalities in the internal organs of the 
experimental animals. 
Long term toxicity study 
In Chronic toxicity study there was no 
behavioural abnormality and mortality throughout 
the study period. Bodyweight was gradually gained in 
A.E. administered rats when compared with the 
vehicle treated rats but it is not statistically 
significant. No significant different in food and water 
consumption was observed in all the animals 
throughout the study. The haematological parameter 
shows the elevated lymphocyte count seen in the low 
and high dose group animals but it become normal in 
post retrieval group animals. In lipid profile the mid 
dose and high dose group animal’s shows significance 
in Total cholesterol and LDL level it was normal in 
post retrieval group animals. 
Figure 1: Body weight (g) changes of albino rats (male and female) exposed to Ayapodi Elagam in 
chronic toxicity study 
 
Table 1: Effect of Ayapodi Elagam on Hepatic Parameters 
Dose (mg/kg) Control  Low dose Mid dose High dose Satellite group 
Total Bilirubin (mg/dl) 0.4±0.10 0.44±0.32 0.5±0.30 0.6±0.40 0.45±0.13 
SGOT(U/L) 86.44±16.6 94.7±21.95 94±21.62 108.83±22.9 137±37.12** 
SGPT(U/L) 28.7±7.8 30.9±5.7 32±9.2 33.7±5.5 31.5±7.6 
Values were expressed as mean± S.D. for N=10 rats in each group one-way ANOVA followed by Dunnett’s test. 
Significant indicates that *P<0.05,**P<0.01 
Table 2: Effect of Ayapodi Elagam on Haematological Parameters 
Parameters Control Low dose Mid dose  High dose Satellite group  
RBC (×106µl) 7.4±0.4 7.6±0.30 7.43±1.34 7.13±1.18 6.6±1.05 
WBC (×103µl) 9.2 ±2.05 8.92±1.2 8.89±2.16 9.15±2.17 7.9±0.9 
PLT (×103µl) 797±108.3 725.±127.3 757.1±152.6 628.83±100.3 735.5±107.2 
HGB (g/dl) 13.58±2.32 13.48±2.01 13.4±1.51 12.61±1.9 14.9±2.3 
Neutrophils (103/mm3) 1.74±0.54 1.92±0.7 1.75±0.45 1.58±0.3 1.72±0.4 
Lymphocyte (%) 73.25±9.08 88.74±10.86** 78.88±8.55 89.35±7.34** 74.8±9.8 
Monocyte (%) 3.39±1.7 3.64±1.6 2.4±1.21 3.68±1.49 3.52±0.7 
Eosinophil’s (%) 1.32±0.26 1.35±0.33 1.36±0.3 1.45±0.23 1.6±0.35 
Basophils (%)       - 1 1      - 0 
MCH (pg) 20.05±3.01 17.93±3.8 18.65±4.2 19.23±3.70 17.85±3.15 
MCV (fl) 58.84±5.13 56.43±5.75 57.96±5.4 59.01±5.03 56.9±4.9 
Values were expressed as mean± S.D. for N=10 rats in each group one-way ANOVA followed by Dunnett’s test. 
Significant indicates that *P<0.05,**P<0.01 
0
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High dose
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Table 3: Effect of Ayapodi Elagam on Renal Parameters 
Dose(mg/kg)  Control  Low dose Mid dose  High dose Satellite group 
BUN(mg/dl) 15.9±3.01 15.7±4.8 15.8±5.0 14.33±6.74 16.2±3.9 
Creatinine (mg/dl) 0.7±0.12 0.8±0.11 0.7±0.2 0.8±0.15 0.75±0.21 
Values were expressed as mean± S.D. for N=10 rats in each group one-way ANOVA followed by Dunnett’s test. 
Significant indicates that *P<0.05, **P<0.01 
Table 4: Effect of Ayapodi Elagam on Biochemical parameters 
Dose (mg/kg) Control  Low dose  Mid dose High dose Satellite group 
Total cholesterol (mg/dl) 137.6±14.20 129.7±10.9 119.09±14.70* 135.8±19.4 148.32±19.45 
HDL (mg/dl) 59.4±8.53 56.9±5.30 60.9±8.3 61.2±8.08 59.75±8.6 
LDL (mg/dl) 62.5±9.64 53.9±9.70 42.7±11.6** 56.33±15.6 69.5±21.64 
VLDL (mg/dl) 15.6±2.50 18.91±4.93 15.5±3.5 18.33±3.7 19.07±2.14 
Triglycerides (mg/dl) 38.5±10.34 36.8±8.40 32.1±9.3 41.33±8.9 36.25±3.8 
Values were expressed as mean± S.D. for N=10 rats in each group one-way ANOVA followed by Dunnett’s test. 
Significant indicates that *P<0.05, **P<0.01. 
Histopathological study 
 The histopathological study the organ such as brain, heart, kidney, liver, lungs, spleen, stomach, uterus, 
ovary and testis were taken. There are no pathological changes observed in all the group of animals. 
Figure 3: Histopathology 
   a) Control (40X)           b) High dose (40X)   c) Satellite group (40X) 
           
Figure 3: Histopathology 
       a) Control (40X)                 b) High dose (40X)       c) Satellite group (40X) 
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Bone marrow study 
 The smear study shows increased network of erythroblastic islets were observed in mid dose level and 
high dose level. 
Spleen 
Testes 
Uterus 
Ovary 
A.Kalaivani et al. Toxicological Profile on Ayapodi Elagam - A Siddha Herbomineral Formulation in Wister Albino Rats 
     Available online at: http://ijapr.in  15 
Fig 2: Microscopic View of Bone Marrow Smear of Rats Low Dose Group mild Dose Group high Dose 
Group 
       
In the bone marrow study Bulky prominent marrow with dense cellular portions were observed and active 
zones of erythropoiesis were observed in sample belong to HD. 
DISCUSSION 
 The Ayapodi Elagam is used for the treatment 
of Pitha Pandu, Pitha Vettai, and Kamalai etc., under 
the Siddha system of medicine. One of the ingredients 
of this medicine was Iron (Ayam), has a long history 
in the treatment of anaemia among Siddha doctors in 
the Tamilnadu. 
 Karisalai have the Hepatoprotective effect[8], 
Analgesic[9], Anti-inflammatory activity[10] and 
Anticancer activity[11] Amla is powerful food for the 
brain. Studies show that Amla helps lower 
cholesterol. Amla also helps maintain the functioning 
of the liver, increases hemoglobin, red blood cell 
count.[12] Keezhanelli have Anti-amnesic[13] Hepato-
protective[14], Diuretic and Immunomodulator 
effect.[15] Honey have Wound healing property[16] and 
Anti-proliferative Effect.[17] 
 Literature reviews reveal that there was no 
such research has been done on Ayapodi Elagam. So I 
would like to study the safety profile of the drug. Its 
safety has been confirmed through acute and long-
term oral toxicity study as per WHO guideline. 
 In acute toxicity study carried out as per 
WHO guidelines there was no treatment related 
death or significance of toxicity developed in albino 
rats at dosage level 5000mg/kg/b.wt throughout the 
study period. (Table 1) Further no gross pathological 
changes have been seen in the internal organs of both 
control and treated groups. Thus the LD50 valve was 
found to be greater than 5000mg/kg/b.wt. 
 To ensure the safety of Ayapodi Elagam long-
term toxicity study was carried out as per WHO 
guideline. Except for hyperactivity at the time of drug 
administration, no other signs of toxicity were noted. 
After the blood collection all the animals were 
euthanized for gross pathological examination of all 
major internal organs. The blood sample was sent to 
a lab for haematology and biochemical analysis. The 
organs were preserved in 10% buffered formalin 
solution before sending for histopathological study. 
All the reports were statistically analyzed. 
  Ayapodi Elagam significant elevation in the 
body weight (Fig 1) and water intake in the test 
group animals when compared with the control 
group during the study period but they were within 
the physiological limit, and this study reveals that it 
does not adversely affect the basal metabolic process 
of the experimental animals. 
 The hemopoietic system serves as an 
important target for the toxic chemicals and a 
sensitive index for pathological condition both in 
humans and animals. In haematological parameters 
(Table 2), it had been observed that lymphocyte 
count was elevated after the administration of 
Ayapodi Elagam at the low dose and high dose group 
animals when compared to control group animals but 
the lymphocyte count was normal in post retrieval 
animals after one month of the drug with drawl. The 
total cholesterol level was reduced in animal treated 
in the Ayapodi Elagam in the mid-dose group but they 
were in the normal limit. Transaminases (SGOT and 
SGPT) are good indicators of liver function and 
biomarkers to predict the possible toxicity of drugs. 
Any elevation pertaining to these enzymes indicate 
their outflow into the bloodstream due to damage in 
liver parenchymal cells. But, there was a marked 
increase in SGOT (Table 1) in Post Retrieval group 
treated animals when compared to control group but 
it was also in the normal range in another group. In 
the present study there was no treatment related 
abnormality in renal functions at all the animals 
(Table 3) and other biochemical parameters (Table 
4) of Ayapodi Elagam treated animals were normal 
when it is administered at higher dose level 
(1800mg/kg). 
 The histopathological study the organ such as 
brain, heart, kidney, liver, lungs, spleen, stomach, 
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uterus, ovary and testis were taken. There is no 
pathological change observed in all the group of 
animals. (Fig 3) 
 The smear study shows an increased network 
of erythroblastic islets was observed in mid-dose 
level. (Fig 2) 
CONCLUSION 
Acute and Long-term toxicity study shows 
that the test drug can be used up to the dose of 
5000mg/kg/b.wt. Ayapodi Elagam produces no 
notable abnormalities were observed in all the group 
of animals. Hence we conclude that the dosage of 
Ayapodi Elagam 2.5 – 5 gm. twice a day narrated in 
Anubogavaithiya Navaneetham is a safer therapeutic 
dose for uses of the human. The smear study shows 
increase erythroblastic islets were observed, so it 
also helps to increase Haemoglobin level for the 
anaemia patient. The author hopes that this study 
will be a food print to further research of 
pharmacological activity, teratogenicity and clinical 
trials regarding Ayapodi Elagam. 
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